These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 29659743)

  • 21. Cardiovascular biomarkers predict post-discharge re-hospitalization risk and mortality among Swedish heart failure patients.
    Molvin J; Jujic A; Bachus E; Gallo W; Tasevska-Dinevska G; Holm H; Melander O; Fedorowski A; Magnusson M
    ESC Heart Fail; 2019 Oct; 6(5):992-999. PubMed ID: 31339668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Addition of Novel Biomarkers for Predicting All-Cause and Cardiovascular Mortality in Prevalent Hemodialysis Patients.
    Yamashita K; Mizuiri S; Nishizawa Y; Shigemoto K; Doi S; Masaki T
    Ther Apher Dial; 2018 Feb; 22(1):31-39. PubMed ID: 28971590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide in Elderly Patients With Valvular Heart Disease.
    Zhang B; Xu H; Zhang H; Liu Q; Ye Y; Hao J; Zhao Q; Qi X; Liu S; Zhang E; Xu Y; Gao R; Pibarot P; Clavel MA; Wu Y;
    J Am Coll Cardiol; 2020 Apr; 75(14):1659-1672. PubMed ID: 32273031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cystatin C and NT-proBNP, a powerful combination of biomarkers for predicting cardiovascular mortality in elderly patients with heart failure: results from a 10-year study in primary care.
    Alehagen U; Dahlström U; Lindahl TL
    Eur J Heart Fail; 2009 Apr; 11(4):354-60. PubMed ID: 19228797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relations of Postload and Fasting Glucose With Incident Cardiovascular Disease and Mortality Late in Life: The Cardiovascular Health Study.
    Brutsaert EF; Shitole S; Biggs ML; Mukamal KJ; deBoer IH; Thacker EL; Barzilay JI; Djoussé L; Ix JH; Smith NL; Kaplan RC; Siscovick DS; Psaty BM; Kizer JR
    J Gerontol A Biol Sci Med Sci; 2016 Mar; 71(3):370-7. PubMed ID: 26314953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apolipoprotein CIII and N-terminal prohormone b-type natriuretic peptide as independent predictors for cardiovascular disease in type 2 diabetes.
    Colombo M; Looker HC; Farran B; Agakov F; Brosnan MJ; Welsh P; Sattar N; Livingstone S; Durrington PN; Betteridge DJ; McKeigue PM; Colhoun HM
    Atherosclerosis; 2018 Jul; 274():182-190. PubMed ID: 29793175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biomarker-Based Risk Model to Predict Cardiovascular Mortality in Patients With Stable Coronary Disease.
    Lindholm D; Lindbäck J; Armstrong PW; Budaj A; Cannon CP; Granger CB; Hagström E; Held C; Koenig W; Östlund O; Stewart RAH; Soffer J; White HD; de Winter RJ; Steg PG; Siegbahn A; Kleber ME; Dressel A; Grammer TB; März W; Wallentin L
    J Am Coll Cardiol; 2017 Aug; 70(7):813-826. PubMed ID: 28797349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular Mortality in Chest Pain Patients: Comparison of Natriuretic Peptides With Novel Biomarkers of Cardiovascular Stress.
    Sinning C; Ojeda F; Zeller T; Zengin E; Rupprecht HJ; Lackner KJ; Bickel C; Blankenberg S; Schnabel RB; Westermann D
    Can J Cardiol; 2016 Dec; 32(12):1470-1477. PubMed ID: 27568502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of multiple emerging biomarkers in cardiovascular risk prediction in patients with stable cardiovascular disease.
    Ahluwalia N; Blacher J; Szabo de Edelenyi F; Faure P; Julia C; Hercberg S; Galan P
    Atherosclerosis; 2013 Jun; 228(2):478-84. PubMed ID: 23582589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cystatin C and estimated glomerular filtration rate as predictors for adverse outcome in patients with ST-elevation and non-ST-elevation acute coronary syndromes: results from the Platelet Inhibition and Patient Outcomes study.
    Akerblom Å; Wallentin L; Siegbahn A; Becker RC; Budaj A; Buck K; Giannitsis E; Horrow J; Husted S; Katus HA; Steg PG; Storey RF; Åsenblad N; James SK
    Clin Chem; 2012 Jan; 58(1):190-9. PubMed ID: 22126936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A combined index of cardiac biomarkers as a risk factor for early cardiovascular mortality in hemodialysis patients.
    Bargnoux AS; Morena M; Jaussent I; Maurice F; Chalabi L; Leray-Moragues H; Terrier N; Dupuy AM; Badiou S; Canaud B; Cristol JP
    Clin Chem Lab Med; 2013 Sep; 51(9):1865-74. PubMed ID: 23399590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive Properties of Biomarkers GDF-15, NTproBNP, and hs-TnT for Morbidity and Mortality in Patients With Type 2 Diabetes With Nephropathy.
    Bidadkosh A; Lambooy SPH; Heerspink HJ; Pena MJ; Henning RH; Buikema H; Deelman LE
    Diabetes Care; 2017 Jun; 40(6):784-792. PubMed ID: 28341782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trajectories of IGF-I Predict Mortality in Older Adults: The Cardiovascular Health Study.
    Sanders JL; Guo W; O'Meara ES; Kaplan RC; Pollak MN; Bartz TM; Newman AB; Fried LP; Cappola AR
    J Gerontol A Biol Sci Med Sci; 2018 Jun; 73(7):953-959. PubMed ID: 28977343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prognostic value of the plasma N-terminal pro-brain natriuretic peptide level on all-cause death and major cardiovascular events in a community-based population.
    Zhu Q; Xiao W; Bai Y; Ye P; Luo L; Gao P; Wu H; Bai J
    Clin Interv Aging; 2016; 11():245-53. PubMed ID: 27013868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Higher circulating adiponectin levels are associated with increased risk of atrial fibrillation in older adults.
    Macheret F; Bartz TM; Djousse L; Ix JH; Mukamal KJ; Zieman SJ; Siscovick DS; Tracy RP; Heckbert SR; Psaty BM; Kizer JR
    Heart; 2015 Sep; 101(17):1368-74. PubMed ID: 25855796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiorenal status using amino-terminal pro-brain natriuretic peptide and cystatin C on cardiac resynchronization therapy outcomes: From the BIOCRT Study.
    Truong QA; Szymonifka J; Januzzi JL; Contractor JH; Deaño RC; Chatterjee NA; Singh JP
    Heart Rhythm; 2019 Jun; 16(6):928-935. PubMed ID: 30590191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relation of Isolated Systolic Hypertension and Pulse Pressure to High-Sensitivity Cardiac Troponin-T and N-Terminal pro-B-Type Natriuretic Peptide in Older Adults (from the Atherosclerosis Risk in Communities Study).
    Madan N; Lee AK; Matsushita K; Hoogeveen RC; Ballantyne CM; Selvin E; McEvoy JW
    Am J Cardiol; 2019 Jul; 124(2):245-252. PubMed ID: 31088661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heart failure mortality according to acute variations in N-terminal pro B-type natriuretic peptide and cystatin C levels.
    Carrasco-Sánchez FJ; Pérez-Calvo JI; Morales-Rull JL; Galisteo-Almeda L; Páez-Rubio I; Barón-Franco B; Aguayo-Canela M; Pujol-De la llave E
    J Cardiovasc Med (Hagerstown); 2014 Feb; 15(2):115-21. PubMed ID: 24522084
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Interplay between Fasting Glucose, Echocardiography, and Biomarkers: Pathophysiological Considerations and Prognostic Implications.
    Pareek M
    Dan Med J; 2017 Sep; 64(9):. PubMed ID: 28874244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Von Willebrand factor improves risk prediction in addition to N-terminal pro-B-type natriuretic peptide in patients referred to coronary angiography and signs and symptoms of heart failure and preserved ejection fraction.
    Kleber ME; Koller L; Goliasch G; Sulzgruber P; Scharnagl H; Silbernagel G; Grammer TB; Delgado G; Tomaschitz A; Pilz S; März W; Niessner A
    Circ Heart Fail; 2015 Jan; 8(1):25-32. PubMed ID: 25342739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.